Psychiatric Advisory Board
Leslie Citrome, MD, MPH
Clinical Professor of Psychiatry and Behavioral Sciences, New York Medical College
Dr. Citrome is a clinical professor of psychiatry and behavioral sciences at New York Medical College in Valhalla, New York, and an adjunct clinical professor of psychiatry at Icahn School of Medicine at Mount Sinai in New York City, New York. In addition to his academic positions, he has a private practice in psychiatry in Pomona, New York. He is a Distinguished Life Fellow of the American Psychiatric Association and a Fellow of the American Society of Clinical Psychopharmacology, where he currently serves as Treasurer.
Dr. Citrome earned his medical degree from McGill University in Montreal, Canada, and his master’s degree in public health from the Columbia University School of Public Health, Division of Health Policy and Management in New York City, New York.
Dr. Citrome is a consultant in clinical trial design and interpretation. He is a frequent lecturer on the quantitative assessment of clinical trial results and has lectured throughout the United States, Canada, Europe, and Asia. His main interests include schizophrenia, bipolar disorder, and major depressive disorder. He is author or coauthor of over 500 research reports, reviews, and chapters in scientific literature. Dr. Citrome is editor-in-chief of the International Journal of Clinical Practice and is on the editorial boards of several publications, including the Journal of Clinical Psychopharmacology, CNS Spectrums, Clinical Psychopharmacology and Neuroscience, and Expert Review of Neurotherapeutics.
Mark Lerman, MD
Principal Investigator, CenExel ACMR
Dr. Lerman has more than 25 years of experience, almost entirely in psychiatric medical research, conducting over 300 studies.
Robert E. Litman, MD
Medical Director and Principal Investigator, CenExel CBH
Dr. Litman is the Medical Director and Principal Investigator for all clinical trials at CenExel CBH. He developed his interest in the treatment of schizophrenia at Massachusetts General Hospital, where he completed his residency in psychiatry. Shortly thereafter, he joined the Experimental Therapeutics Branch, National Institute of Mental Health, NIH, as a Senior Staff Fellow. He remained at NIH until 1995, where he continued to pursue his interest in schizophrenia, including investigating the effects of atypical neuroleptics biological and genetic markers in schizophrenia, as well as the development of better combination therapies for schizophrenia using the alpha-2 antagonist idazoxan. After leaving the NIH, he formed his own clinical trials research organization, first in conjunction with area hospitals, and then as a free-standing inpatient and outpatient clinical research organization now known as CBH Health. Since then, he has conducted over 300 Phase I-IV clinical trials and has participated in many of the important advances in pharmacotherapy of schizophrenia and other brain disorders.
Dr. Litman has an extensive background in psychopharmacology, the evaluation and treatment of schizophrenia, bipolar, major depression, anxiety, and Alzheimer disease. He serves as a consultant in psychopharmacology to many area hospitals and group practices, has over 30 academic publications, and frequently speaks about new advances in the field of psychopharmacology, and on the current issues regarding drug development for psychiatric illness. He is currently an Associate Professor of Psychiatry at Georgetown University Medical School (where he teaches and trains Psychiatry residents) and a Fellow and Diplomate of the American Board of Psychiatry and Neurology and Diplomate, Added Qualifications in Geriatric Psychiatry.
Robert A. Riesenberg, MD
Medical Director, CenExel ACMR
Dr. Riesenberg is the founder and principal investigator for CenExel ACMR. A research psychiatrist with four decades of experience, Dr. Riesenberg’s primary focus is on CNS, PK, healthy normal, and child/adolescent disorders. Dr. Riesenberg has been the principal investigator in over 600 studies.
Dr. Riesenberg earned a bachelor’s degree in both Zoology and Psychology from Memphis State University in 1972. In 1975, he earned his MD from the University of Tennessee. He is licensed to practice in Georgia.
Peter Ventre, MD
President and Founder, CenExel RCA
President and Founder, Ventre Medical Associates
Chief of Psychiatry, Broward Health Medical Center
Within the research community, Dr. Peter Ventre has built a strong reputation over the years as being a diligent and insightful investigator. With experience in more than 125 clinical trials, he ensures excellent patient care and thorough involvement in the research process.
Dr. Ventre is board certified in psychiatry by the American Board of Psychiatry and Neurology. He completed his Bachelor of Science degree in Biology and Science from the University of Puerto Rico and continued his medical studies at San Juan Bautista School of Medicine in Caguas, Puerto Rico. He earned his medical degree from the Universidad Iberoamericana, Santo Domingo and completed residencies at the Mount Sinai School of Medicine and Cabrini Medical Center for Internal Medicine and Psychiatry. He then completed his psychiatry residency at the University of Florida Psychiatry Program.
In addition to being a principal investigator at CenExel RCA, Dr. Ventre is the owner of one of Broward County’s largest group practices, Ventre Medical Associates (VMA). VMA provides a quality referral source for potential RCA research subjects. VMA is also contracted with Broward Health, Broward County’s largest hospital system, to provide all psychiatric services for two of their largest hospitals: Broward Health Medical Center and Broward Health Imperial Point. Dr. Ventre serves as Chief of Psychiatry at Broward Health Medical Center.